YZ
0000-0001-5383-3207 About
I received medical training at the Fourth Military Medical University (Xian, China) and did a Ph.D. in Immunology at University of Toronto. Since 2004, I have been a professor in the Department of Immunology, Peking University. My research interest is focused on lymphocyte development and differentiation of effector T cells. More recently, much effort has also been made to develop new strategies for tumor immunotherapy.
Employment
-
Jinzhou Medical University Director2017 - Present
-
Peking University Professor2004 - Present
Education
-
University of Toronto PhD1991 - 1997
Projects & Funding
Projects & funding information is unavailable.
Publications (92)
- Exploring RPA1-ETAA1 axis via high-throughput data analysis: implications for PD-L1 nuclear translocation and tumor-immune dynamics in liver cancer Save
- Lymphocyte homing and recirculation with tumor tertiary lymphoid structure formation: predictions for successful cancer immunotherapy Save
- Cholesterol neutralized vemurafenib treatment by promoting melanoma stem-like cells via its metabolite 27-hydroxycholesterol Save
- CBX4 promotes antitumor immunity by suppressing Pdcd1 expression in T cells Save
- Hierarchical transcriptional network governing heterogeneous T cell exhaustion and its implications for immune checkpoint blockade Save
- The PRAK-NRF2 axis promotes the differentiation of Th17 cells by mediating the redox homeostasis and glycolysis Save
- Prostaglandin E2–Induced AKT Activation Regulates the Life Span of Short-Lived Plasma Cells by Attenuating IRE1α Hyperactivation Save
- Up-regulated DNA-binding inhibitor Id3 promotes differentiation of regulatory T cell to influence antiviral immunity in chronic hepatitis B virus infection Save
- CBX4 Provides an Alternate Mode of Colon Cancer Development via Potential Influences on Circadian Rhythm and Immune Infiltration Save
- PRAK Promotes the Pathogen Clearance by Macrophage Through Regulating Autophagy and Inflammasome Activation Save